davunetide
Jump to navigation
Jump to search
Mechanism of action
- promotes microtubule stability
- reduces tau phosphorylation
Clinical trials
- davunetide is not effective for treatment of prgressive supranuclear palsy
More general terms
References
- ↑ Boxer AL et al. Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol 2014 Jul; 13:676 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24873720 <Internet> http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70088-2/fulltext